TCR2 Therapeutics Inc.
TCRR · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $33 | $54 | $44 |
| Short-Term Investments | $96 | $116 | $122 | $162 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $5 | $8 | $10 |
| Total Curr. Assets | $140 | $178 | $184 | $216 |
| Property Plant & Equip (Net) | $9 | $29 | $87 | $90 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $11 | $31 | $89 | $92 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $152 | $208 | $273 | $308 |
| Liabilities | – | – | – | – |
| Payables | $6 | $3 | $3 | $5 |
| Short-Term Debt | $3 | $50 | $21 | $21 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $38 | $11 | $13 | $13 |
| Total Curr. Liab. | $47 | $64 | $37 | $39 |
| LT Debt | $3 | $3 | $38 | $43 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $38 | $43 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $50 | $67 | $74 | $82 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$542 | -$501 | -$441 | -$410 |
| AOCI | -$0 | -$0 | -$1 | -$1 |
| Other Equity | $643 | $643 | $640 | $637 |
| Total Equity | $101 | $141 | $199 | $226 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $152 | $208 | $273 | $308 |
| Net Debt | -$8 | $21 | $4 | $20 |